- The overall quality of evidence supporting interventions to reduce surgical site infection in adult heart surgery is poor. Studies used varying definitions for wound infection, which meant that it ...
Reduced heart function is a potentially fatal complication after heart surgery. A possible approach to prevent this complication is treatment with drugs that stimulate the contraction of the heart (so ...
Nearly half (47%) of all clinical trials remain unpublished. Whether a trial is published and how long it takes is influenced by whether there are positive results, how large the trial is and if it is ...
• Fenoldopam (a medicine that rapidly widens and relaxes blood vessels) probably reduces the risk of developing acute kidney injury (AKI) (a condition where the kidneys suddenly lose their ability to ...
Mike: Hello, I’m Mike Clarke, podcast editor for the Cochrane Library. Globally, postpartum haemorrhage is responsible for a quarter of maternal deaths after childbirth. Tears of the perineum, which ...
– Taking high doses (more than 1000 mg) of calcium supplements during pregnancy may lead to slightly fewer babies being born before 37 weeks of pregnancy. There was possibly no difference in unwanted ...
Prophylactic TXA in addition to standard care during caesarean birth results in little to no difference in estimated blood loss ≥ 1000 mL and likely results in a slight reduction in calculated blood ...
Perineal HAase injection during the second stage of labour may result in a lower incidence of perineal trauma (tears or episiotomy, or both) compared with no intervention, but not compared with ...
Compared to placebo, galantamine (when given at a total dose of 16 mg to 24 mg/day) slows the decline in cognitive function, functional ability, and behaviour at six months in people with dementia due ...
The website for the 23rd Cochrane Colloquium, taking place in Vienna from 3-7 October 2015, is now live. Get the latest ...
在CKD和糖尿病患者中,SGLT2抑制剂单独使用或与标准护理联合使用,能够减少全因死亡、心血管死亡和肾衰竭的风险,并且可能降低主要心血管事件的发生率,同时相比安慰剂,发生低血糖的 ...
El documentalista del Grupo Cochrane de Hipertensión (Cochrane Hypertension) buscó ensayos controlados aleatorizados en las siguientes bases de datos hasta abril de 2018 y de nuevo en marzo de 2020: ...